. | FDA eligible for metformin (sCr <1.4 mg/dL for women; <1.5 mg/dL for men) . | |||
---|---|---|---|---|
Overall study N . | Metformin self-report . | |||
Study N . | % . | National estimate (N) . | ||
All | 3,269 | 1,331 | 40.7 | 6,517,600 |
MDRD eGFR <30 mL/min/1.73 m2 | 0 | 0 | 0 | 0 |
MDRD eGFR 30–44 mL/min/1.73 m2 | 53 | 18 | 34.0 | 85,400 |
MDRD eGFR ≥45 mL/min/1.73 m2 | 3,216 | 1,313 | 40.8 | 6,432,200 |
. | FDA eligible for metformin (sCr <1.4 mg/dL for women; <1.5 mg/dL for men) . | |||
---|---|---|---|---|
Overall study N . | Metformin self-report . | |||
Study N . | % . | National estimate (N) . | ||
All | 3,269 | 1,331 | 40.7 | 6,517,600 |
MDRD eGFR <30 mL/min/1.73 m2 | 0 | 0 | 0 | 0 |
MDRD eGFR 30–44 mL/min/1.73 m2 | 53 | 18 | 34.0 | 85,400 |
MDRD eGFR ≥45 mL/min/1.73 m2 | 3,216 | 1,313 | 40.8 | 6,432,200 |
Weights used to produce U.S. national estimates.